Yumanity Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 41
Employees
  • Stock Symbol
  • YMTX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $19.90
  • (As of Friday Closing)

Yumanity Therapeutics General Information

Description

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's advanced product candidate, YTX-7739, which is in phase 1 clinical development for Parkinson's disease.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NAS
Primary Office
  • 40 Guest Street
  • Suite 4410
  • Boston, MA 02135
  • United States
+1 (617) 000-0000

Yumanity Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Yumanity Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.90 $20.22 $16.27 - $23.47 $201M 10.1M 80.6K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Yumanity Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.

Request a free trial

Yumanity Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development
Drug Discovery
Boston, MA
41 As of 2020
00000
000000000000 00000

000000 0

dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Toronto, Canada
0 As of 0000
000.00
000000000 000.00

00000000

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt m
0000 000000000
Cambridge, MA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Yumanity Therapeutics Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProMIS Neurosciences Corporation Toronto, Canada 0 000.00 000000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, MA 00 000.00 0000000000 0 000.00
0000000 Private Equity-Backed San Diego, CA 000 00000 000000000 - 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 0000 00000000000 0000
0000 Venture Capital-Backed San Diego, CA 00 00.000 0000000000 0
You’re viewing 5 of 26 competitors. Get the full list »

Yumanity Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Richard Peters Ph.D Chief Executive Officer & Board Member
Paulash Mohsen Chief Financial Officer, Finance & Executive
Ellen Forest Chief Human Resources Officer
Daniel Tardiff Ph.D Scientific Co-founder & Director, Discovery Biology
Vikram Khurana MD Scientific Co-Founder & Senior Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

Yumanity Therapeutics Board Members (13)

Name Representing Role Since
Cecil Pickett Ph.D Yumanity Therapeutics Board Member 000 0000
David Arkowitz Self Board Member 000 0000
Jeffery Kelly Ph.D Self Board Member 000 0000
Joel Marcus JD Alexandria Venture Investments Board Member 000 0000
John Cox Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Yumanity Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yumanity Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.

Request a free trial

Yumanity Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 22-Dec-2020 000000000000000000 Drug Discovery 0000000 000000 00.0
To view Yumanity Therapeutics’s complete acquisitions history, request access »